GENFIT Pipeline Day Highlights Diverse Product Portfolio in

Phase 3 data for elafibranor in primary biliary cholangitis (PBC) expected in 2Q23Expanded pipeline now covers five therapeutic areas with high unmet...

Related Keywords

Germany ,United States ,Massachusetts ,Madrid ,Spain ,California ,France ,Switzerland ,Jenniferc Lai ,Pascal Prigent ,John Hopkins ,Angela Lamarca ,Mark Yarchoan ,Jonel Trebicka ,Genoscience Pharma ,Department Of Internal Medicine ,University Of California ,Drug Administration ,Nasdaq ,Fundacion Jimenez Diaz University Hospital ,Pipeline Program ,Euronext ,Pipeline Day ,New York ,Chief Executive Officer ,Expert Speakers ,Transplant Hepatologist ,Internal Medicine ,Associate Professor ,Medical Oncology ,Bay Life Science Advisors ,Key Opinion Leaders ,Child Pugh Score ,Orphan Drug Designation ,Paris Stock Exchange Gnft ,Genfit Sa ,